Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study - PubMed (original) (raw)
Review
Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study
Sudha Seshadri et al. Lancet Neurol. 2007 Dec.
Abstract
The main neurological causes of morbidity and mortality are stroke and dementia. We contend that the most relevant and readily communicated risk estimate for stroke and dementia is lifetime risk, which is the probability of someone of a given age and sex developing a condition during their remaining lifespan. Lifetime risk estimates describe the population burden; however, they can be refined with risk-stratified models to enable individual risk prediction. Community-based data on a group of North Americans of European descent indicate that the lifetime risk of stroke for a middle-aged woman is 1 in 5 and for a middle-aged man is 1 in 6. The lifetime risk of stroke was equal to the lifetime risk of dementia and equal to or greater than the lifetime risk of Alzheimer's disease (1 in 5 and 1 in 10 for women and men, respectively), and the lifetime risk of stroke or dementia was greater than 1 in 3. Thus, the lifetime burden attributable to common neurological disease is immense.
Similar articles
- Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study.
Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, White R, D'Agostino RB. Seshadri S, et al. Neurology. 1997 Dec;49(6):1498-504. doi: 10.1212/wnl.49.6.1498. Neurology. 1997. PMID: 9409336 - Lifetime risk of common neurological diseases in the elderly population.
Licher S, Darweesh SKL, Wolters FJ, Fani L, Heshmatollah A, Mutlu U, Koudstaal PJ, Heeringa J, Leening MJG, Ikram MK, Ikram MA. Licher S, et al. J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):148-156. doi: 10.1136/jnnp-2018-318650. Epub 2018 Oct 2. J Neurol Neurosurg Psychiatry. 2019. PMID: 30279211 - The lifetime risk of stroke: estimates from the Framingham Study.
Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. Seshadri S, et al. Stroke. 2006 Feb;37(2):345-50. doi: 10.1161/01.STR.0000199613.38911.b2. Epub 2006 Jan 5. Stroke. 2006. PMID: 16397184 - Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis.
Pendlebury ST, Rothwell PM. Pendlebury ST, et al. Lancet Neurol. 2009 Nov;8(11):1006-18. doi: 10.1016/S1474-4422(09)70236-4. Epub 2009 Sep 24. Lancet Neurol. 2009. PMID: 19782001 Review. - Brain health and shared risk factors for dementia and stroke.
Gardener H, Wright CB, Rundek T, Sacco RL. Gardener H, et al. Nat Rev Neurol. 2015 Nov;11(11):651-7. doi: 10.1038/nrneurol.2015.195. Epub 2015 Oct 20. Nat Rev Neurol. 2015. PMID: 26481296 Review.
Cited by
- Assessment of Lifetime Risk for Cardiovascular Disease: Time to Move Forward.
Sigala EG, Panagiotakos DB. Sigala EG, et al. Curr Cardiol Rev. 2024;20(6):e030724231561. doi: 10.2174/011573403X311031240703080650. Curr Cardiol Rev. 2024. PMID: 38963102 Free PMC article. Review. - Association between cognitive function and ambient particulate matters in middle-aged and elderly Chinese adults: Evidence from the China Health and Retirement Longitudinal Study (CHARLS).
Yao Y, Wang K, Xiang H. Yao Y, et al. Sci Total Environ. 2022 Jul 1;828:154297. doi: 10.1016/j.scitotenv.2022.154297. Epub 2022 Mar 11. Sci Total Environ. 2022. PMID: 35288137 Free PMC article. - Postmenopausal hormone therapy: an Endocrine Society scientific statement.
Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW, Jarjour WN, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian WH; Endocrine Society. Santen RJ, et al. J Clin Endocrinol Metab. 2010 Jul;95(7 Suppl 1):s1-s66. doi: 10.1210/jc.2009-2509. Epub 2010 Jun 21. J Clin Endocrinol Metab. 2010. PMID: 20566620 Free PMC article. Review. - Risk Prediction Models for Post-Stroke Dementia.
Tang EYH, Robinson L, Stephan BCM. Tang EYH, et al. Geriatrics (Basel). 2017 Jun 22;2(3):19. doi: 10.3390/geriatrics2030019. Geriatrics (Basel). 2017. PMID: 31011029 Free PMC article. - An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer's disease.
De Roeck A, Duchateau L, Van Dongen J, Cacace R, Bjerke M, Van den Bossche T, Cras P, Vandenberghe R, De Deyn PP, Engelborghs S, Van Broeckhoven C, Sleegers K; BELNEU Consortium. De Roeck A, et al. Acta Neuropathol. 2018 Jun;135(6):827-837. doi: 10.1007/s00401-018-1841-z. Epub 2018 Mar 27. Acta Neuropathol. 2018. PMID: 29589097 Free PMC article.
Publication types
MeSH terms
Grants and funding
- N01-HC-25195/HC/NHLBI NIH HHS/United States
- R01 NS017950/NS/NINDS NIH HHS/United States
- NS17950/NS/NINDS NIH HHS/United States
- AG08122/AG/NIA NIH HHS/United States
- AG16495/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical